About Us
Real-time Quotes & News
Market Analysis
Trading Platform
Terms
Promotion
FAQ
Contact
繁
简
EN
繁
简
EN
Promotion
FAQ
Contact
Open Account
Contact Us

According to CNBC, Eli Lilly's CEO stated that the company opposes the move to legislate Trump's drug pricing agreement.

2026-04-02

According to CNBC, Eli Lilly's CEO stated that the company opposes the move to legislate Trump's drug pricing agreement.

Other News
2026-04-01

1. The People's Bank of China (PBOC) has completed high-quality statistics on local government financing platform debt, enhancing the sensitivity and forward-looking nature of its situation analysis. 2. The PBOC recommends leveraging the integrated

1. The People's Bank of China (PBOC) has completed high-quality statistics on local government financing platform debt, enhancing the sensitivity and forward-looking nature of its situation analysis. 2. The PBOC recommends leveraging the integrated effect of incremental and existing policies, comprehensively utilizing various tools, and strengthening monetary policy regulation. 3. Arrangements for second-quarter treasury bond issuance have been announced; institutions believe issuance is expected to increase significantly in the second quarter. 4. Issuance of new special-purpose bonds accelerated and investment targets optimized in the first quarter. 5. Since the outbreak of the Iran-Iraq War, global central banks have sold $81.5 billion in US Treasury bonds. 6. The Shanghai Stock Exchange has issued 142.8 billion yuan of science and technology innovation bonds this year, an increase of 83% year-on-year. 7. The bond market briefly respite from "troop withdrawal expectations," but sentiment remains fragile ahead of Easter. 8. ETF trading volume in the two markets exceeded 400 billion yuan, with bond ETFs accounting for more than half. 9. The first-quarter 2026 bond underwriting rankings have been released, with Bank of China, China Construction Bank, and Industrial and Commercial Bank of China ranking as the top three bank underwriters. 10. 154 bonds totaling 142.8 billion yuan were issued, representing an 83% increase in the issuance of science and technology innovation bonds on the Shanghai Stock Exchange in the first quarter.
2026-04-01

XIAOMI: DELIVERED MORE THAN 7,000 NEW-GEN SU7 UNITS SINCE MARCH 23

XIAOMI: DELIVERED MORE THAN 7,000 NEW-GEN SU7 UNITS SINCE MARCH 23
Open Account
Demo Account
Contact Us
About Us Real-time Quotes & News Market Analysis
 Trading Platform Market Analysis Promotion Terms Promotion FAQ Contact
Copyright © 2026 Aspire Global Company Limited. All Rights Reserved.
Terms of Use and Privacy
Disclaimer

Disclaimer: ASPIRE is not responsible for the content of any analysis, advice, comment, suggestion, research report or market data in this website and links to third-party websites or resources. All the information mentioned above only represents the view of corresponding author. ASPIRE cannot and does not warrant the accuracy, validity, timeliness or completeness of any such information. You should conduct individual assessments and other proper research to make their investment decisions. The materials and information contained in this website are provided for reference only and do not constitute or form an offer, invitation, solicitation or investment advice or recommendation to acquire or dispose of any investment products or services. The price of any financial instruments described in this website may fall as well as rise. Past performance should not be taken as an indication of future performance. The risk disclosure statements do not purport to disclose or discuss all of the risks and other significant aspects of any financial instruments mentioned in this website. You should make your own appraisal of the risk and should consult to the extent necessary your own legal, tax, financial or other professional advisers in respect of any financial instruments mentioned in this website prior to entering into any transaction.

Risk Warning: Leveraged Precious Metals trading on margin carries significant risks and is not suitable for all investors. Please be sure to make investments within your own tolerance after fully understand the risks involved.

Registered & Business Address: Room 1905-1906, 19/F, Eastern Commercial Centre, 395-399 Hennessy Road, Hong Kong

Aspire Global Company Limited is not available to provide services for the residents of certain jurisdictions such as Afghanistan, the United States of America, the Islamic Republic of Iran, North Korean.